Re: Researchers make slow headway in managing dry mouth.
作者信息
LeVeque F
出版信息
J Natl Cancer Inst. 1997 Dec 17;89(24):1894-5. doi: 10.1093/jnci/89.24.1894-a.
PMID:9414180
Abstract
摘要
相似文献
1
Re: Researchers make slow headway in managing dry mouth.
J Natl Cancer Inst. 1997 Dec 17;89(24):1894-5. doi: 10.1093/jnci/89.24.1894-a.
2
The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
Semin Arthritis Rheum. 1999 Jun;28(6):360-7. doi: 10.1016/s0049-0172(99)80002-x.
3
4
Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
Eur J Nucl Med. 1999 Mar;26(3):220-5. doi: 10.1007/s002590050380.
5
Systemic pilocarpine for treatment of xerostomia.
Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1333-40. doi: 10.1517/17425255.4.10.1333.
6
Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
Rheumatology (Oxford). 2016 Feb;55(2):237-45. doi: 10.1093/rheumatology/kev278. Epub 2015 Sep 2.
7
Oral pilocarpine (Salagen)--a recently approved salivary stimulant.
Gen Dent. 1996 Jan-Feb;44(1):26, 29-30.
8
Salivary enhancement: current status and future therapies.
J Dent Educ. 2001 Oct;65(10):1096-101.
9
Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
J Am Dent Assoc. 1997 Aug;128(8):1128-33. doi: 10.14219/jada.archive.1997.0371.
10
Pilocarpine treatment of xerostomia in head and neck patients.
Micron. 2002;33(2):153-5. doi: 10.1016/s0968-4328(01)00004-x.
Zotero 插件